These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38386232)

  • 41. Dihydrotanshinone I inhibits gallbladder cancer growth by targeting the Keap1-Nrf2 signaling pathway and Nrf2 phosphorylation.
    Li Z; Mo RL; Gong JF; Han L; Wang WF; Huang DK; Xu JG; Sun YJ; Chen S; Han GC; Sun DQ
    Phytomedicine; 2024 Jul; 129():155661. PubMed ID: 38677269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The MondoA-dependent TXNIP/GDF15 axis predicts oxaliplatin response in colorectal adenocarcinomas.
    Deng J; Pan T; Wang D; Hong Y; Liu Z; Zhou X; An Z; Li L; Alfano G; Li G; Dolcetti L; Evans R; Vicencio JM; Vlckova P; Chen Y; Monypenny J; Gomes CAC; Weitsman G; Ng K; McCarthy C; Yang X; Hu Z; Porter JC; Tape CJ; Yin M; Wei F; Rodriguez-Justo M; Zhang J; Tejpar S; Beatson R; Ng T
    EMBO Mol Med; 2024 Sep; 16(9):2080-2108. PubMed ID: 39103698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Elevating H3K27me3 level sensitizes colorectal cancer to oxaliplatin.
    Wang Q; Chen X; Jiang Y; Liu S; Liu H; Sun X; Zhang H; Liu Z; Tao Y; Li C; Hu Y; Liu D; Ye D; Liu Y; Wang M; Zhang X
    J Mol Cell Biol; 2020 Feb; 12(2):125-137. PubMed ID: 31065671
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in colorectal cancer.
    Huang Y; Chan S; Chen S; Liu X; Li M; Zheng L; Dong Z; Yang Z; Liu Z; Zhou D; Zhang X; Zhang B
    J Transl Med; 2024 Feb; 22(1):133. PubMed ID: 38310229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer.
    Ju HQ; Lu YX; Wu QN; Liu J; Zeng ZL; Mo HY; Chen Y; Tian T; Wang Y; Kang TB; Xie D; Zeng MS; Huang P; Xu RH
    Oncogene; 2017 Nov; 36(45):6282-6292. PubMed ID: 28692052
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin.
    Yang C; Zhang Y; Lin S; Liu Y; Li W
    Aging (Albany NY); 2021 Mar; 13(10):13515-13534. PubMed ID: 33819186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer.
    Chen ZH; Qi JJ; Wu QN; Lu JH; Liu ZX; Wang Y; Hu PS; Li T; Lin JF; Wu XY; Miao L; Zeng ZL; Xie D; Ju HQ; Xu RH; Wang F
    J Exp Clin Cancer Res; 2019 May; 38(1):196. PubMed ID: 31088567
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-153-5p promotes sensibility of colorectal cancer cells to oxaliplatin via targeting Bcl-2-mediated autophagy pathway.
    He Y; Zhang L; Tan F; Wang LF; Liu DH; Wang RJ; Yin XZ
    Biosci Biotechnol Biochem; 2020 Aug; 84(8):1645-1651. PubMed ID: 32380907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thioredoxin domain-containing protein 9 (TXNDC9) contributes to oxaliplatin resistance through regulation of autophagy-apoptosis in colorectal adenocarcinoma.
    Zhou W; Fang C; Zhang L; Wang Q; Li D; Zhu D
    Biochem Biophys Res Commun; 2020 Apr; 524(3):582-588. PubMed ID: 32029274
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Downregulation of chemoresistance by claudin-14 silencing in human colorectal cancer cells.
    Mizukami Y; Ito A; Hashimoto S; Ando T; Ishikawa Y; Eguchi H; Yoshino Y; Matsunaga T; Ikari A
    Arch Biochem Biophys; 2024 Aug; 758():110075. PubMed ID: 38942107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro exosomal transfer of Nrf2 led to the oxaliplatin resistance in human colorectal cancer LS174T cells.
    Mostafazadeh M; Kahroba H; Haiaty S; TazeKand AP; Samadi N; Rahbarghazi R; Nouri M
    Cell Biochem Funct; 2022 Jun; 40(4):391-402. PubMed ID: 35474580
    [TBL] [Abstract][Full Text] [Related]  

  • 52. WBSCR22 confers oxaliplatin resistance in human colorectal cancer.
    Yan D; Tu L; Yuan H; Fang J; Cheng L; Zheng X; Wang X
    Sci Rep; 2017 Nov; 7(1):15443. PubMed ID: 29133897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional Regulation of GDF15 by EGR1 Promotes Head and Neck Cancer Progression through a Positive Feedback Loop.
    Jin Y; Jung SN; Lim MA; Oh C; Piao Y; Kim HJ; Liu L; Kang YE; Chang JW; Won HR; Song K; Koo BS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis.
    Lu YX; Ju HQ; Wang F; Chen LZ; Wu QN; Sheng H; Mo HY; Pan ZZ; Xie D; Kang TB; Chen G; Yun JP; Zeng ZL; Xu RH
    Cancer Lett; 2016 Sep; 380(1):87-97. PubMed ID: 27322737
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer.
    Huang C; Wang M; Wang J; Wu D; Gao Y; Huang K; Yao X
    Biochem Pharmacol; 2021 Jul; 189():114390. PubMed ID: 33359068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nrf2 inhibition increases sensitivity to chemotherapy of colorectal cancer by promoting ferroptosis and pyroptosis.
    Huang Y; Yang W; Yang L; Wang T; Li C; Yu J; Zhang P; Yin Y; Li R; Tao K
    Sci Rep; 2023 Sep; 13(1):14359. PubMed ID: 37658132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway.
    Liu X; Su K; Sun X; Jiang Y; Wang L; Hu C; Zhang C; Lu M; Du X; Xing B
    J Exp Clin Cancer Res; 2021 Apr; 40(1):132. PubMed ID: 33858476
    [TBL] [Abstract][Full Text] [Related]  

  • 58. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. lncRNA-encoded pep-AP attenuates the pentose phosphate pathway and sensitizes colorectal cancer cells to Oxaliplatin.
    Wang X; Zhang H; Yin S; Yang Y; Yang H; Yang J; Zhou Z; Li S; Ying G; Ba Y
    EMBO Rep; 2022 Jan; 23(1):e53140. PubMed ID: 34779552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.
    Jiang Z; Hou Z; Liu W; Yu Z; Liang Z; Chen S
    Bioengineered; 2022 Jan; 13(1):810-823. PubMed ID: 34974791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.